(Q44443169)
Statements
Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions (English)
Dietger Niederwieser
Alistair G Reid
Evelin Hennig
Christina Franke
Andre Brizard
Julie Freeman-Edward
Gavin Cuthbert
Nick Bown
Richard E Clark
Elizabeth P Nacheva
Michael W N Deininger